Literature DB >> 10797387

Understanding neuromyotonia.

A Vincent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797387     DOI: 10.1002/(sici)1097-4598(200005)23:5<655::aid-mus1>3.0.co;2-e

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  7 in total

1.  KCNQ2 is a nodal K+ channel.

Authors:  Jérôme J Devaux; Kleopas A Kleopa; Edward C Cooper; Steven S Scherer
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

Review 2.  [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

3.  Excitability properties of motor axons in patients with spontaneous motor unit activity.

Authors:  M C Kiernan; I K Hart; H Bostock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

Review 4.  [Isaacs' syndrome. Diagnosis and differential diagnosis of neuromyotonia].

Authors:  D Fischer; R Schröder
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

5.  Focal neuromyotonia as a presenting feature of lumbosacral radiculopathy.

Authors:  Tushar Premraj Raut; Ravindra Kumar Garg; Tejendra Singh Chaudhari; Hardeep Singh Malhotra; Maneesh Kumar Singh
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

6.  The episodic ataxia type 1 mutation I262T alters voltage-dependent gating and disrupts protein biosynthesis of human Kv1.1 potassium channels.

Authors:  Szu-Han Chen; Ssu-Ju Fu; Jing-Jia Huang; Chih-Yung Tang
Journal:  Sci Rep       Date:  2016-01-18       Impact factor: 4.379

7.  Mercury Toxicity Following Unauthorized Siddha Medicine Intake - A Mimicker of Acquired Neuromyotonia - Report of 32 Cases.

Authors:  G Gnanashanmugam; R Balakrishnan; S P Somasundaram; N Parimalam; P Rajmohan; M B Pranesh
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.